A critical advance in cancer investigation is occurring with the use of nanobodies to re-engage damaged p53. This essential malignant protector protein is frequently inactivated in various forms of malignancies, https://bookmarkshq.com/story23832342/mini-antibodies-revive-tumor-suppressor-p53-the-potential-hope-for-tumor-therapy